Skip to main content
Clinical Trials/ACTRN12613001193763
ACTRN12613001193763
Completed
未知

A prospective in-group comparison of the efficacy and safety of fully closed-loop control ventilation (Intellivent-ASV (Registered Trademark)) with conventional adaptive support ventilation (ASV) and synchronized intermittent mandatory ventilation (SIMV) modes in adult critically ill patients in the medical intensive care unit.

Dr PV van Heerden0 sites20 target enrollmentOctober 30, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr PV van Heerden
Enrollment
20
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 30, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr PV van Heerden

Eligibility Criteria

Inclusion Criteria

  • All patients admitted to our MICU and who will be ventilated for at least 24 hours prior to recruitment are eligible for inclusion. Patients included will also be required to have had stable hemodynamic and respiratory parameters over the previous 12 hours.

Exclusion Criteria

  • We will exclude patients due for extubation on the same day, patients with unstable hemodynamic parameters (labile blood pressure or pulse rate or escalating vasopressor or inotrope requirements), those requiring mandatory ventilation (such as pressure controlled ventilation) or who are receiving inhaled nitric oxide. Pregnant women and minors (age less than 18 years) will also be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials